FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Börse Stuttgart 11:24:59 03/07/2024 pm IST | ||
| 0.143 EUR | -7.74% |
|
| Current month | -10.06% | ||
| 1 month | -10.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.143 | -7.74% |
| 02/24/02 | 0.155 | -3.13% |
| 01/24/01 | 0.16 | +0.63% |
| 28/24/28 | 0.159 | +3.25% |
| 27/24/27 | 0.154 | +6.21% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 11:24 pm IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MC2RXY |
| ISIN | DE000MC2RXY3 |
| Date issued | 17/07/2019 |
| Strike | 152.6 $ |
| Maturity | Unlimited |
| Parity | 459.56 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.07 € |
|---|---|
| Lowest since issue | 0.094 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
224.6
USD
Average target price
283.2
USD
Spread / Average Target
+26.06%
- Stock Market
- Certificates
- Certificat
